These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 11959842)

  • 1. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex.
    Rayman JB; Takahashi Y; Indjeian VB; Dannenberg JH; Catchpole S; Watson RJ; te Riele H; Dynlacht BD
    Genes Dev; 2002 Apr; 16(8):933-47. PubMed ID: 11959842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
    Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107 x E2F and p130 x E2F complexes.
    Catchpole S; Tavner F; Le Cam L; Sardet C; Watson RJ
    J Biol Chem; 2002 Oct; 277(41):39015-24. PubMed ID: 12147683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
    Stiegler P; De Luca A; Bagella L; Giordano A
    Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon.
    Thomas NS; Pizzey AR; Tiwari S; Williams CD; Yang J
    J Biol Chem; 1998 Sep; 273(37):23659-67. PubMed ID: 9726970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
    Macaluso M; Cinti C; Russo G; Russo A; Giordano A
    Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus.
    Zini N; Trimarchi C; Claudio PP; Stiegler P; Marinelli F; Maltarello MC; La Sala D; De Falco G; Russo G; Ammirati G; Maraldi NM; Giordano A; Cinti C
    J Cell Physiol; 2001 Oct; 189(1):34-44. PubMed ID: 11573202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SWI/SNF activity is required for the repression of deoxyribonucleotide triphosphate metabolic enzymes via the recruitment of mSin3B.
    Gunawardena RW; Fox SR; Siddiqui H; Knudsen ES
    J Biol Chem; 2007 Jul; 282(28):20116-23. PubMed ID: 17510060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene.
    Chang YC; Illenye S; Heintz NH
    Mol Cell Biol; 2001 Feb; 21(4):1121-31. PubMed ID: 11158299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.
    Hurford RK; Cobrinik D; Lee MH; Dyson N
    Genes Dev; 1997 Jun; 11(11):1447-63. PubMed ID: 9192872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
    Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
    Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation.
    Richon VM; Lyle RE; McGehee RE
    J Biol Chem; 1997 Apr; 272(15):10117-24. PubMed ID: 9092557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes.
    Timchenko NA; Wilde M; Iakova P; Albrecht JH; Darlington GJ
    Nucleic Acids Res; 1999 Sep; 27(17):3621-30. PubMed ID: 10446255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation.
    Vairo G; Soos TJ; Upton TM; Zalvide J; DeCaprio JA; Ewen ME; Koff A; Adams JM
    Mol Cell Biol; 2000 Jul; 20(13):4745-53. PubMed ID: 10848600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest.
    Iavarone A; Massagué J
    Mol Cell Biol; 1999 Jan; 19(1):916-22. PubMed ID: 9858615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
    Cobrinik D; Whyte P; Peeper DS; Jacks T; Weinberg RA
    Genes Dev; 1993 Dec; 7(12A):2392-404. PubMed ID: 8253385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells.
    Balciunaite E; Spektor A; Lents NH; Cam H; Te Riele H; Scime A; Rudnicki MA; Young R; Dynlacht BD
    Mol Cell Biol; 2005 Sep; 25(18):8166-78. PubMed ID: 16135806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.